Abrahams, A., Mowla, S., Parker, M. I., Goding, C. R., and Prince, S. (2008).
UV-mediated regulation of the anti-senescence factor Tbx2. J. Biol. Chem. 283,
2223–2230.
Aksan, I., and Goding, C. R. (1998). Targeting the microphthalmia basic
helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements
in vitro and in vivo. Mol. Cell. Biol. 18, 6930–6938.
Amellem, O., Stokke, T., Sandvik, J. A., and Pettersen, E. O. (1996). The
retinoblastoma gene product is reversibly dephosphorylated and bound in
the nucleus in S and G2 phases during hypoxic stress. Exp. Cell Res. 227,
106–115.
Bandyopadhyay, D., and Medrano, E. E. (2000). Melanin accumulation accelerates
melanocyte senescence by a mechanism involving p16INK4a/CDK4/
pRB and E2F1. Ann. NY Acad. Sci. 908, 71–84.
Bilican, B., and Goding, C. R. (2006). Cell cycle regulation of the T-box
transcription factor tbx2. Exp. Cell Res. 312, 2358–2366.
Boogerd, K. J., Wong, L. Y., Christoffels, V. M., Klarenbeek, M., Ruijter, J. M.,
Moorman, A. F., and Barnett, P. (2008). Msx1 and Msx2 are functional interacting
partners of T-box factors in the regulation of connexin43. Cardiovasc.
Res. 78, 485–493.
Brehm, A., and Kouzarides, T. (1999). Retinoblastoma protein meets chromatin.
Trends Biochem. Sci. 24, 142–145.
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., and
Kouzarides, T. (1998). Retinoblastoma protein recruits histone deacetylase to
repress transcription. Nature 391, 597–601.
Butz, N. V., Campbell, C. E., and Gronostajski, R. M. (2004). Differential target
gene activation by TBX2 and TBX2VP16, evidence for activation domaindependent
modulation of gene target specificity. Gene 342, 67–76.
Carlson, H., Ota, S., Song, Y., Chen, Y., and Hurlin, P. J. (2002). Tbx3 impinges
on the p53 pathway to suppress apoptosis, facilitate cell transformation and
block myogenic differentiation. Oncogene 21, 3827–3835.
Carreira, S., Dexter, T. J., Yavuzer, U., Easty, D. J., and Goding, C. R. (1998).
Brachyury-related transcription factor Tbx2 and repression of the melanocytespecific
TRP-1 promoter. Mol. Cell. Biol. 18, 5099–5108.
Carreira, S., Goodall, J., Aksan, I., La Rocca, S. A., Galibert, M. D., Denat, L.,
Larue, L., and Goding, C. R. (2005). Mitf cooperates with Rb1 and activates
p21Cip1 expression to regulate cell cycle progression. Nature 433, 764–769.
Chen, J., Zhong, Q., Wang, J., Cameron, R. S., Borke, J. L., Isales, C. M., and
Bollag, R. J. (2001). Microarray analysis of Tbx2-directed gene expression: a
possible role in osteogenesis. Mol. Cell. Endocrinol. 177, 43–54.
Chen, J. R., Chatterjee, B., Meyer, R., Yu, J. C., Borke, J. L., Isales, C. M., Kirby,
M. L., Lo, C. W., and Bollag, R. J. (2004). Tbx2 represses expression of
Connexin43 in osteoblastic-like cells. Calcif. Tissue Int. 74, 561–573.
Chen, P. L., Riley, D. J., Chen-Kiang, S., and Lee, W. H. (1996a). Retinoblastoma
protein directly interacts with and activates the transcription factor
NF-IL6. Proc. Natl. Acad. Sci. USA 93, 465–469.
Chen, P. L., Riley, D. J., Chen, Y., and Lee, W. H. (1996b). Retinoblastoma
protein positively regulates terminal adipocyte differentiation through direct
interaction with C/EBPs. Genes Dev. 10, 2794–2804.
Conlon, F. L., Fairclough, L., Price, B. M., Casey, E. S., and Smith, J. C. (2001).
Determinants of T box protein specificity. Development 128, 3749–3758.
Dai, M., et al. (2005). Evolving gene/transcript definitions significantly alter
the interpretation of GeneChip data. Nucleic Acids Res. 33, e175.
Davis, E., Teng, H., Bilican, B., Parker, M. I., Liu, B., Carriera, S., Goding, C. R.,
and Prince, S. (2007). Ectopic Tbx2 expression results in polyploidy and
cisplatin resistance. Oncogene 27, 976–984.
Demay, F., Bilican, B., Rodriguez, M., Carreira, S., Pontecorvi, M., Ling, Y.,
and Goding, C. R. (2007). T-box factors: targeting to chromatin and interaction
with the histone H3 N-terminal tail. Pigment Cell Res. 20, 279–287.
Dunaief, J. L., Strober, B. E., Guha, S., Khavari, P. A., Alin, K., Luban, J.,
Begemann, M., Crabtree, G. R., and Goff, S. P. (1994). The retinoblastoma
protein and BRG1 form a complex and cooperate to induce cell cycle arrest.
Cell 79, 119–130.
Fajas, L., Paul, C., Zugasti, O., Le Cam, L., Polanowska, J., Fabbrizio, E.,
Medema, R., Vignais, M. L., and Sardet, C. (2000). pRB binds to and modulates
the transrepressing activity of the E1A-regulated transcription factor
p120E4F. Proc. Natl. Acad. Sci. USA 97, 7738–7743.
Gentleman, R. C., et al. (2004). Bioconductor: open software development for
computational biology and bioinformatics. Genome Biol. 5, R80.
Harrelson, Z., Kelly, R. G., Goldin, S. N., Gibson-Brown, J. J., Bollag, R. J.,
Silver, L. M., and Papaioannou, V. E. (2004). Tbx2 is essential for patterning
the atrioventricular canal and for morphogenesis of the outflow tract during
heart development. Development 131, 5041–5052.
Herrmann, B. G., Labeit, S., Poustka, A., King, T. R., and Lehrach, H. (1990).
Cloning of the T gene required in mesoderm formation in the mouse. Nature
343, 617–622.
Hiroi, Y., Kudoh, S., Monzen, K., Ikeda, Y., Yazaki, Y., Nagai, R., and Komuro,
I. (2001). Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte
differentiation. Nat. Genet. 28, 276–280.
Hitachi, K., Danno, H., Tazumi, S., Aihara, Y., Uchiyama, H., Okabayashi, K.,
Kondow, A., and Asashima, M. (2009). The Xenopus Bowline/Ripply family
proteins negatively regulate the transcriptional activity of T-box transcription
factors. Int. J. Dev. Biol. 53, 631–639.
Hoek, K., et al. (2004). Expression profiling reveals novel pathways in the
transformation of melanocytes to melanomas. Cancer Res. 64, 5270–5282.
Ishida, S., Huang, E., Zuzan, H., Spang, R., Leone, G., West, M., and Nevins,
J. R. (2001). Role for E2F in control of both DNA replication and mitotic
functions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21,
4684–4699.
Jacobs, J. J., et al. (2000). Senescence bypass screen identifies TBX2, which
represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast
cancers. Nat. Genet. 26, 291–299.
Jonsson, G., Dahl, C., Staaf, J., Sandberg, T., Bendahl, P. O., Ringner, M.,
Guldberg, P., and Borg, A. (2007). Genomic profiling of malignant melanoma
using tiling-resolution arrayCGH. Oncogene 26, 4738–4748.
Kawamura, A., Koshida, S., and Takada, S. (2008). Activator-to-repressor
conversion of T-box transcription factors by the Ripply family of Groucho/
TLE-associated mediators. Mol. Cell. Biol. 28, 3236–3244.
Lamolet, B., Pulichino, A. M., Lamonerie, T., Gauthier, Y., Brue, T., Enjalbert,
A., and Drouin, J. (2001). A pituitary cell-restricted T box factor, Tpit, activates
POMC transcription in cooperation with Pitx homeoproteins. Cell 104, 849–
859.
Lavender, P., Vandel, L., Bannister, A. J., and Kouzarides, T. (1997). The
HMG-box transcription factor HBP1 is targeted by the pocket proteins and
E1A. Oncogene 14, 2721–2728.
Lewis, M. D., Miller, S. A., Miazgowicz, M. M., Beima, K. M., and Weinmann,
A. S. (2007). T-bet’s ability to regulate individual target genes requires the
conserved T-box domain to recruit histone methyltransferase activity and a
separate family member-specific transactivation domain. Mol. Cell. Biol. 27,
8510–8521.
Lingbeek, M. E., Jacobs, J. J., and van Lohuizen, M. (2002). The T-box repressors
TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF
via a variant T-site in the initiator. J. Biol. Chem. 277, 26120–26127.
Linke, S. P., Harris, M. P., Neugebauer, S. E., Clarkin, K. C., Shepard, H. M.,
Maneval, D. C., and Wahl, G. M. (1997). p53-mediated accumulation of
hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle
progression. Oncogene 15, 337–345.
Lipinski, M. M., and Jacks, T. (1999). The retinoblastoma gene family in
differentiation and development. Oncogene 18, 7873–7882.
Lomnytska, M., Dubrovska, A., Hellman, U., Volodko, N., and Souchelnytskyi,
S. (2006). Increased expression of cSHMT, Tbx3 and utrophin in
plasma of ovarian and breast cancer patients. Int. J. Cancer 118, 412–421.
Lyng, H., Brovig, R. S., Svendsrud, D. H., Holm, R., Kaalhus, O., Knutstad, K.,
Oksefjell, H., Sundfor, K., Kristensen, G. B., and Stokke, T. (2006). Gene
expressions and copy numbers associated with metastatic phenotypes of
uterine cervical cancer. BMC Genom. 7, 268.
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le
Villain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. (1998). Retinoblastoma
protein represses transcription by recruiting a histone deacetylase.
Nature 391, 601–605.
Mahlamaki, E. H., Barlund, M., Tanner, M., Gorunova, L., Hoglund, M.,
Karhu, R., and Kallioniemi, A. (2002). Frequent amplification of 8q24, 11q,
17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer
35, 353–358.
Maira, M., Couture, C., Le Martelot, G., Pulichino, A. M., Bilodeau, S., and
Drouin, J. (2003). The T-box factor Tpit recruits SRC/p160 co-activators and
mediates hormone action. J. Biol. Chem. 278, 46523–46532.
Markey, M. P., Angus, S. P., Strobeck, M. W., Williams, S. L., Gunawardena,
R. W., Aronow, B. J., and Knudsen, E. S. (2002). Unbiased analysis of RBmediated
transcriptional repression identifies novel targets and distinctions
from E2F action. Cancer Res. 62, 6587–6597.
Martini, E., Roche, D. M., Marheineke, K., Verreault, A., and Almouzni, G.
(1998). Recruitment of phosphorylated chromatin assembly factor 1 to chromatin
after UV irradiation of human cells. J. Cell Biol. 143, 563–575.
Melnikova, V. O., Bolshakov, S. V., Walker, C., and Ananthaswamy, H. N.
(2004). Genomic alterations in spontaneous and carcinogen-induced murine
melanoma cell lines. Oncogene 23, 2347–2356.
Messenger, N. J., Kabitschke, C., Andrews, R., Grimmer, D., Nunez Miguel,
R., Blundell, T. L., Smith, J. C., and Wardle, F. C. (2005). Functional specificity
of the Xenopus T-domain protein Brachyury is conferred by its ability to
interact with Smad1. Dev. Cell 8, 599–610.
Michaloglou, C., Vredeveld, L. C., Soengas, M. S., Denoyelle, C., Kuilman, T.,
van der Horst, C. M., Majoor, D. M., Shay, J. W., Mooi, W. J., and Peeper, D. S.
(2005). BRAFE600-associated senescence-like cell cycle arrest of human naevi.
Nature 436, 720–724.
Miller, S. A., Huang, A. C., Miazgowicz, M. M., Brassil, M. M., and
Weinmann, A. S. (2008). Coordinated but physically separable interaction
with H3K27-demethylase and H3K4-methyltransferase activities are required
for T-box protein-mediated activation of developmental gene expression.
Genes Dev. 22, 2980–2993.
Mittnacht, S. (1998). Control of pRB phosphorylation. Curr. Opin. Genet Dev.
8, 21–27.
Morris, E. J., and Dyson, N. J. (2001). Retinoblastoma protein partners. Adv.
Cancer Res. 82, 1–54.
Muller, C. W., and Herrmann, B. G. (1997). Crystallographic structure of the
T domain-DNA complex of the Brachyury transcription factor. Nature 389,
884–888.
Muller, H., Bracken, A. P., Vernell, R., Moroni, M. C., Christians, F., Grassilli,
E., Prosperini, E., Vigo, E., Oliner, J. D., and Helin, K. (2001). E2Fs regulate the
expression of genes involved in differentiation, development, proliferation,
and apoptosis. Genes Dev. 15, 267–285.
Naef, F., and Magnasco, M. O. (2003). Solving the riddle of the bright mismatches:
labeling and effective binding in oligonucleotide arrays. Phys. Rev.
E. Stat. Nonlin. Soft Matter Phys. 68, 011906
Nead, M. A., Baglia, L. A., Antinore, M. J., Ludlow, J. W., and McCance, D. J.
(1998). Rb binds c-Jun and activates transcription. EMBO J. 17, 2342–2352.
Nielsen, S. J., et al. (2001). Rb targets histone H3 methylation and HP1 to
promoters. Nature 412, 561–565.
Paxton, C., Zhao, H., Chin, Y., Langner, K., and Reecy, J. (2002). Murine Tbx2
contains domains that activate and repress gene transcription. Gene 283,
117–124.
Polager, S., Kalma, Y., Berkovich, E., and Ginsberg, D. (2002). E2Fs upregulate
expression of genes involved in DNA replication, DNA repair and
mitosis. Oncogene 21, 437–446.
Prince, S., Carreira, S., Vance, K. W., Abrahams, A., and Goding, C. R. (2004).
Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent
kinase inhibitor. Cancer Res. 64, 1669–1674.
Pulichino, A. M., Vallette-Kasic, S., Tsai, J. P., Couture, C., Gauthier, Y., and
Drouin, J. (2003). Tpit determines alternate fates during pituitary cell differentiation.
Genes Dev. 17, 738–747.
Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R. A., and
Dynlacht, B. D. (2002). E2F integrates cell cycle progression with DNA repair,
replication, and G(2)/M checkpoints. Genes Dev. 16, 245–256.
Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., and
Wolffe, A. P. (2000). DNMT1 forms a complex with Rb, E2F1 and HDAC1 and
represses transcription from E2F-responsive promoters. Nat. Genet 25, 338–
342.
Rodriguez-Esteban, C., Tsukui, T., Yonei, S., Magallon, J., Tamura, K., and
Izpisua Belmonte, J. C. (1999). The T-box genes Tbx4 and Tbx5 regulate limb
outgrowth and identity. Nature 398, 814–818.
Rodriguez, M., Aladowicz, E., Lanfrancone, L., and Goding, C. R. (2008). Tbx3
represses E-cadherin expression and enhances melanoma invasiveness. Cancer
Res. 68, 7872–7881.
Shih, H. H., Tevosian, S. G., and Yee, A. S. (1998). Regulation of differentiation
by HBP1, a target of the retinoblastoma protein. Mol. Cell. Biol. 18, 4732–4743.
Sinclair, C. S., et al. (2002). TBX2 is preferentially amplified in BRCA1- and
BRCA2-related breast tumors. Cancer Res. 62, 3587–3591.
Sinha, S., Abraham, S., Gronostajski, R. M., and Campbell, C. E. (2000).
Differential DNA binding and transcription modulation by three T-box proteins,
T, TBX1 and TBX2. Gene 258, 15–29.
Suarez-Farinas, M., Pellegrino, M., Wittkowski, K. M., and Magnasco, M. O.
(2005). Harshlight: a “corrective make-up” program for microarray chips.
BMC Bioinform. 6, 294.
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., and Glimcher,
L. H. (2000). A novel transcription factor, T-bet, directs Th1 lineage commitment.
Cell 100, 655–669.
Takeuchi, J. K., Koshiba-Takeuchi, K., Matsumoto, K., Vogel-Hopker, A.,
Naitoh-Matsuo, M., Ogura, K., Takahashi, N., Yasuda, K., and Ogura, T.
(1999). Tbx5 and Tbx4 genes determine the wing/leg identity of limb buds.
Nature 398, 810–814.
Tevosian, S. G., Shih, H. H., Mendelson, K. G., Sheppard, K. A., Paulson, K. E.,
and Yee, A. S. (1997). HBP1, a HMG box transcriptional repressor that is
targeted by the retinoblastoma family. Genes Dev. 11, 383–396.
Tong, Y., Aune, T., and Boothby, M. (2005). T-bet antagonizes mSin3a recruitment
and transactivates a fully methylated IFN-gamma promoter via a conserved
T-box half-site. Proc. Natl. Acad. Sci. USA 102, 2034–2039.
Trouche, D., Le Chalony, C., Muchardt, C., Yaniv, M., and Kouzarides, T.
(1997). RB and hbrm cooperate to repress the activation functions of E2F1.
Proc. Natl. Acad. Sci. USA 94, 11268–11273.
Vance, K. W., Carreira, S., Brosch, G., and Goding, C. R. (2005). Tbx2 is
overexpressed and plays an important role in maintaining proliferation and
suppression of senescence in melanomas. Cancer Res. 65, 2260–2268.
Vormer, T. L., Foijer, F., Wielders, C. L., and te Riele, H. (2008). Anchorageindependent
growth of pocket protein-deficient murine fibroblasts requires
bypass of G2 arrest and can be accomplished by expression of TBX2. Mol.
Cell. Biol. 28, 7263–7273.
Yavuzer, U., Keenan, E., Lowings, P., Vachtenheim, J., Currie, G., and Goding,
C. R. (1995). The Microphthalmia gene product interacts with the retinoblastoma
protein in vitro and is a target for deregulation of melanocyte-specific
transcription. Oncogene 10, 123–134.
Yu, B. D., Becker-Hapak, M., Snyder, E. L., Vooijs, M., Denicourt, C., and
Dowdy, S. F. (2003). Distinct and nonoverlapping roles for pRB and cyclin
D:cyclin-dependent kinases 4/6 activity in melanocyte survival. Proc. Natl.
Acad. Sci. USA 100, 14881–14886.